-
1
Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities
Published 2025-05-01Subjects: Get full text
Article -
2
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Published 2025-02-01Subjects: Get full text
Article -
3
Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP‐Deficient Glioma May Be Influenced by Surrounding Normal Cells
Published 2024-12-01Subjects: Get full text
Article -
4
A systematic literature review of MTAP deletions in solid and hematologic Cancers
Published 2025-01-01Subjects: Get full text
Article -
5
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy
Published 2025-09-01Subjects: “…MTAP…”
Get full text
Article -
6
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder
Published 2025-07-01Subjects: “…MTAP deficiency…”
Get full text
Article -
7
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
Published 2025-01-01Subjects: “…MTAP…”
Get full text
Article -
8
The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma
Published 2023-06-01Subjects: Get full text
Article